Yahan Yu

967 total citations · 1 hit paper
21 papers, 747 citations indexed

About

Yahan Yu is a scholar working on Molecular Biology, Immunology and Surgery. According to data from OpenAlex, Yahan Yu has authored 21 papers receiving a total of 747 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Immunology and 3 papers in Surgery. Recurrent topics in Yahan Yu's work include Inflammasome and immune disorders (4 papers), CCD and CMOS Imaging Sensors (3 papers) and Analog and Mixed-Signal Circuit Design (3 papers). Yahan Yu is often cited by papers focused on Inflammasome and immune disorders (4 papers), CCD and CMOS Imaging Sensors (3 papers) and Analog and Mixed-Signal Circuit Design (3 papers). Yahan Yu collaborates with scholars based in China, Taiwan and Nigeria. Yahan Yu's co-authors include Yunlong Bai, Ying� Qin, Lihong Wang, Hui Che, Yueqiu Wang, Jie Lv, Fan Yang, Huimin Xian, Songyan Meng and Yang Li and has published in prestigious journals such as Diabetes Care, European Journal of Pharmacology and Frontiers in Pharmacology.

In The Last Decade

Yahan Yu

19 papers receiving 739 citations

Hit Papers

Metformin Inhibits the NLRP3 Inflammasome via AMPK/mTOR-d... 2019 2026 2021 2023 2019 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yahan Yu China 9 511 126 124 119 106 21 747
Xueli Cai China 15 529 1.0× 130 1.0× 206 1.7× 81 0.7× 148 1.4× 25 849
Ruijuan Wang China 14 293 0.6× 59 0.5× 160 1.3× 101 0.8× 53 0.5× 43 694
Bo Jin China 15 248 0.5× 99 0.8× 65 0.5× 165 1.4× 69 0.7× 43 652
Bi Cheng Liu China 16 386 0.8× 129 1.0× 90 0.7× 85 0.7× 130 1.2× 29 871
Er Yue China 11 532 1.0× 58 0.5× 237 1.9× 133 1.1× 85 0.8× 14 671
Xiao Chuan-shi China 15 321 0.6× 121 1.0× 237 1.9× 225 1.9× 145 1.4× 34 820
Zuyi Yuan China 14 287 0.6× 100 0.8× 40 0.3× 135 1.1× 89 0.8× 40 655
Debora Collotta Italy 17 408 0.8× 137 1.1× 43 0.3× 75 0.6× 122 1.2× 35 798
Jin Shang China 20 480 0.9× 115 0.9× 106 0.9× 84 0.7× 143 1.3× 56 999

Countries citing papers authored by Yahan Yu

Since Specialization
Citations

This map shows the geographic impact of Yahan Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yahan Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yahan Yu more than expected).

Fields of papers citing papers by Yahan Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yahan Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yahan Yu. The network helps show where Yahan Yu may publish in the future.

Co-authorship network of co-authors of Yahan Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Yahan Yu. A scholar is included among the top collaborators of Yahan Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yahan Yu. Yahan Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Yahan, et al.. (2025). A ramp-based background calibration technique for timing mismatch in time-interleaved ADCs. AEU - International Journal of Electronics and Communications. 193. 155717–155717.
2.
Sun, Xi, Yahan Yu, Yujie Chen, et al.. (2024). Overexpressing of the GIPC1 protects against pathological cardiac remodelling. European Journal of Pharmacology. 971. 176488–176488. 2 indexed citations
3.
Han, Shisong, Yahan Yu, Qi Ding, et al.. (2024). Lenvatinib in hepatocellular carcinoma: Resistance mechanisms and strategies for improved efficacy. Liver International. 44(8). 1808–1831. 33 indexed citations
4.
Yu, Yahan, et al.. (2023). Stroke Extraction of Chinese Character Based on Deep Structure Deformable Image Registration. Proceedings of the AAAI Conference on Artificial Intelligence. 37(1). 1360–1367. 4 indexed citations
5.
Yu, Yahan, Xi Sun, Chaorun Dong, et al.. (2023). miR-135 protects against atrial fibrillation by suppressing intracellular calcium-mediated NLRP3 inflammasome activation. Journal of Cell Communication and Signaling. 17(3). 813–825. 5 indexed citations
6.
Yu, Yahan, et al.. (2023). A 12-bit 625 MS/s Time-interleaved Pipelined ADC. 538–542. 1 indexed citations
7.
Yu, Yahan, Bojie Hu, & Yu Li. (2022). GHAN: Graph-Based Hierarchical Aggregation Network for Text-Video Retrieval. 5547–5557. 5 indexed citations
9.
Sun, Xi, Chaorun Dong, Yahan Yu, et al.. (2022). Daming capsule protects against myocardial infarction by promoting mitophagy via the SIRT1/AMPK signaling pathway. Biomedicine & Pharmacotherapy. 151. 113162–113162. 10 indexed citations
10.
Yu, Yahan, Yixuan Xu, Jian Wang, Zhenxing Li, & Bin Cao. (2022). Anti-Money Laundering Risk Identification of Financial Institutions based on Aspect-Level Graph Neural Networks. 542–546. 1 indexed citations
11.
Jiang, Yanan, Hongguang Wang, Yahan Yu, et al.. (2021). HIV Tat Protein Induces Myocardial Fibrosis Through TGF-β1-CTGF Signaling Cascade: A Potential Mechanism of HIV Infection-Related Cardiac Manifestations. Cardiovascular Toxicology. 21(12). 965–972. 9 indexed citations
12.
Chen, Yenan, Yao-Jen Chang, Hsin‐Hui Wang, et al.. (2021). The functional characterization of phosphorylation of tristetraprolin at C-terminal NOT1-binding domain. Journal of Inflammation. 18(1). 22–22. 5 indexed citations
13.
Yue, Er, Yahan Yu, Xinyao Wang, et al.. (2021). Anthocyanin Protects Cardiac Function and Cardiac Fibroblasts From High-Glucose Induced Inflammation and Myocardial Fibrosis by Inhibiting IL-17. Frontiers in Pharmacology. 11. 593633–593633. 29 indexed citations
14.
Kuan, Chen‐Hsiang, et al.. (2021). Resuming Oral Feeding in Patients With Oral Squamous Cell Carcinoma With Free Anterolateral Thigh Flap Reconstruction. Annals of Plastic Surgery. 86(2S). S108–S112. 3 indexed citations
16.
Liao, Wei‐Chih, Yahan Yu, Cheng‐Chieh Huang, et al.. (2019). Galectin-3 and S100A9: Novel Diabetogenic Factors Mediating Pancreatic Cancer–Associated Diabetes. Diabetes Care. 42(9). 1752–1759. 27 indexed citations
17.
Yang, Fan, Anqi Li, Ying� Qin, et al.. (2019). A Novel Circular RNA Mediates Pyroptosis of Diabetic Cardiomyopathy by Functioning as a Competing Endogenous RNA. Molecular Therapy — Nucleic Acids. 17. 636–643. 104 indexed citations
18.
Yang, Fan, Ying� Qin, Yueqiu Wang, et al.. (2019). Metformin Inhibits the NLRP3 Inflammasome via AMPK/mTOR-dependent Effects in Diabetic Cardiomyopathy. International Journal of Biological Sciences. 15(5). 1010–1019. 355 indexed citations breakdown →
19.
Li, Anqi, Yahan Yu, Xueying Ding, et al.. (2019). MiR-135b protects cardiomyocytes from infarction through restraining the NLRP3/caspase-1/IL-1β pathway. International Journal of Cardiology. 307. 137–145. 44 indexed citations
20.
Yue, Er, Gulnara Tuguzbaeva, Xi Chen, et al.. (2018). Anthocyanin is involved in the activation of pyroptosis in oral squamous cell carcinoma. Phytomedicine. 56. 286–294. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026